Lidocaine dose-response effect on postoperative cognitive deficit: meta-analysis and meta-regression

Expert Rev Clin Pharmacol. 2018 Apr;11(4):361-371. doi: 10.1080/17512433.2018.1425614. Epub 2018 Jan 19.

Abstract

The true influence of the perioperative intravenous lidocaine on the development of postoperative cognitive deficit (POCD) in coronary artery bypass grafting (CABG) remains controversial. The principal aim is to undertake a meta-regression to determine whether moderator variables mediate the relationship between lidocaine and POCD. Areas covered: We searched the Web of Science, PubMed database, Scopus and the Cochrane Library database (up to June 2017) and systematically reviewed a list of retrieved articles. Our final review includes only randomized controlled trials (RCTs) that compared infusion of lidocaine and placebo during cardiopulmonary bypass (CPB). Mantel-Haenszel risk ratio (MH RR) and corresponding 95% confidence interval (CI) was used to report the overall effect and meta-regression analysis. A total of 688 patients in five RCTs were included. POCD occurred in 34% of all cases. Perioperative lidocaine reduces POCD (MH RR 0.702 (95% CI: 0.541-0.909). Younger age, male gender, longer CPB and higher concentration of lidocaine significantly mediate the relationship between lidocaine and POCD in favour of the neuroprotective effect of lidocaine. Expert commentary: The neuroprotective effect of lidocaine on POCD is consistent in spite of longer CPB time. A higher concentration of lidocaine strengthened the neuroprotective effect of lidocaine.

Keywords: Lidocaine; coronary artery bypass grafting; meta-regression; postoperative cognitive deficit.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Cognition Disorders / etiology
  • Cognition Disorders / prevention & control*
  • Coronary Artery Bypass / adverse effects
  • Coronary Artery Bypass / methods
  • Dose-Response Relationship, Drug
  • Humans
  • Lidocaine / administration & dosage*
  • Neuroprotective Agents / administration & dosage*
  • Postoperative Complications / prevention & control
  • Randomized Controlled Trials as Topic
  • Regression Analysis
  • Risk Factors
  • Time Factors

Substances

  • Neuroprotective Agents
  • Lidocaine